<DOC>
	<DOCNO>NCT01411189</DOCNO>
	<brief_summary>Patients require therapeutic upper gastrointestinal endoscopy , polypectomy , endoscopic hemostasis , percutaneous endoscopic gastrostomy ( PEG ) , endoscopic mucosal resection ( EMR ) endoscopic submucosal dissection ( ESD ) , receive intragastric spray NPO-11 . The efficacy NPO-11 anti-peristaltic agent endoscopic therapeutic procedure evaluate base proportion patient suppress gastric peristalsis procedure . The degree gastric peristalsis assess independent committee . The safety NPO-11 evaluate base adverse event adverse drug reaction ( ADRs ) observe administration seven day administration .</brief_summary>
	<brief_title>Phase III Open-labeled Study NPO-11 Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>Inpatients outpatient either sex require therapeutic upper gastrointestinal endoscopy meet criterion ( 1 ) , ( 4 ) , ( 6 ) one ( 2 ) , ( 3 ) ( 5 ) study . Patients provide write informed consent voluntary participation study . The criterion ( 2 ) ( 4 ) confirm endoscopic observation start intend treatment . 1 . Patients require therapeutic upper gastrointestinal endoscopy ( polypectomy , endoscopic hemostasis , PEG , EMR ESD ) 2 . Patients differentiatedtype intramucosal gastric cancer locate upper middle third stomach ( ≤2 cm size , ulcer finding , EMR ESD ) 3 . Patients gastric adenoma ( ≤2 cm size , ulcer finding , EMR ESD ) 4 . Patients single intended lesion treatment 5 . Patients without experience PEG tube placement case PEG tube placement 6 . Patients older 20 year time consent Patients meet follow criterion exclude study beforehand . The criterion ( 3 ) ( 4 ) confirm endoscopic observation start intend treatment . 1 . Patients history surgery upper gastrointestinal tract 2 . Patients require emergency endoscopy 3 . Patients severe gastric stenosis deformation make observation gastric peristalsis difficult 4 . Patients require emergency endoscopic treatment except intend lesion 5 . Patients ongoing cancer treatment ( chemotherapy radiotherapy ) 6 . Patients pacemaker 7 . Patients know bleeding tendency Patients difficulty antithrombogenic agent withdrawal 8 . Patients history shock hypersensitivity lmenthol peppermint oil 9 . Pregnant lactate woman , woman childbearing potential , woman plan become pregnant study 10 . Patients receive investigational drug within four month consent participate clinical study 11 . Patients otherwise ineligible participation study investigator 's opinion</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>therapeutic upper gastrointestinal endoscopy</keyword>
	<keyword>percutaneous endoscopic gastrostomy</keyword>
	<keyword>endoscopic mucosal resection</keyword>
	<keyword>endoscopic submucosal dissection</keyword>
	<keyword>PEG</keyword>
	<keyword>EMR</keyword>
	<keyword>ESD</keyword>
	<keyword>endoscopic hemostasis</keyword>
</DOC>